alg-055009
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 30, 2021 (NCT05090111)
Timeline
Indications
Mechanism of action
THRB agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06959888 | Phase 1 | Mar 25, 2025 | Aligos Therapeutics |
| NCT06342947 | Phase 2 | Apr 1, 2024 | Aligos Therapeutics |
| NCT06191991 | Phase 1 | Nov 3, 2023 | Aligos Therapeutics |
| NCT05090111 | Phase 1 | Nov 30, 2021 | Aligos Therapeutics |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Aligos Therapeutics | For profit | 4 | 4 | 2 | 2021 |
1 organizations
Page 1 / 1